topics of interest in mds: the role of maintenance therapy, immune checkpoints & ven-aza in hr-mds
Published 2 years ago • 52 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
4:27
the role of immune checkpoint inhibitors in mds
-
2:04
state-of-the-art treatment for hr-mds
-
3:10
the role of ngs in mds diagnosis
-
2:16
current and future treatment approaches for hr-mds
-
1:13
the importance of cd47 as a target in mds and aml
-
5:42
immune checkpoint inhibitors in mds and aml
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
2:43
novel therapies in the future of mds treatment
-
7:54
patient/caregiver stories - living with mds
-
13:39
key highlights in mds: treating lower-risk & higher-risk disease, trial updates, and more
-
5:22
magrolimab azacitidine in mds and aml
-
1:16
state of the art: mds
-
1:30
the prognostic value of patient-reported outcomes in mds
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
4:44
immunotherapy in mds
-
1:34
perspectives on the management of low and high-risk mds
-
11:33
treatment algorithm for low-risk mds
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
1:19
the promise of precision medicine in mds
-
2:53
immune checkpoint inhibitors in mds: the i4mds consortium
-
1:22
key advances in mds management
-
1:17
exciting novel treatments being developed for mds